RAC 2.11% $1.63 race oncology ltd

Yes the crystalisation problem remained to be solved even if...

  1. 19,195 Posts.
    lightbulb Created with Sketch. 6197
    Yes the crystalisation problem remained to be solved even if Lederle had chosen to abandon bisantrene because their CEO hated the colour orange.

    This crystalisation problem is now solved, the IP is vastly stronger and broader, and we now know and can advance the massive CPACS and m6A RNA opportunities.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.63
Change
-0.035(2.11%)
Mkt cap ! $278.6M
Open High Low Value Volume
$1.68 $1.68 $1.61 $91.17K 56.05K

Buyers (Bids)

No. Vol. Price($)
2 4572 $1.63
 

Sellers (Offers)

Price($) Vol. No.
$1.64 804 2
View Market Depth
Last trade - 12.21pm 06/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.